Kala Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
KALA Kala Pharmaceuticals Inc
LXFR Luxfer Holdings PLC
SHOO Steven Madden Ltd
FISV Fiserv Inc
UFI Unifi Inc
SSTK Shutterstock Inc
CSGP CoStar Group Inc
OBELF Obsidian Energy Ltd
RCKY Rocky Brands Inc
HSBC HSBC Holdings PLC
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles, or MPP, technology. The Company’s initial focus is on the treatment of eye diseases. The Company’s product candidate includes KPI-121 1%, KPI-121 0.25% and MPP rTKI Program. The Company has completed two Phase III clinical trials for KPI-121 1% . The KPI-121 0.25% is the Company’s product candidate for temporary relief of signs and symptoms of dry eye disease. KPI-121 1% is the twice-a-day product candidate for treatment of post-operative inflammation and pain following ocular surgery. MPP rTKI Program is therapies for retinal diseases that should be injected directly into the patient's eye, often at monthly intervals.

Closing Price
$6.28
Day's Change
-1.45 (-18.72%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.70
Day's Low
6.07
Volume
(Heavy Day)
Volume:
8,694,559

10-day average volume:
1,758,144
8,694,559
  • Prev Close
    7.72
  • Today's Open
    7.65
  • Day's Range
    6.07-7.70
  • Avg Vol (10-day)
    1.8M
  • Last (time)
    4:00p ET 10/27/20
  • Last (size)
    184
  • 52-Wk Range
    3.45 - 14.68
    LowHigh
  • (11/07/19 - 06/03/20)
    81.88%
  • 85.6%
  • Market Cap
    351.8M
  • Shares Outstanding
    56.1M
  • -2.26
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 87.27
  • (% of float 10/15/20)
    11.03

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.